Finance

Lists
CSBR:NASDAQ
Champions Oncology Inc
USDย 4,64
-0,85%
(-0,040) 1D
17 Nov., 10:50:28 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CSBR...
Open
USDย 4,70
High
USDย 4,70
Low
USDย 4,60
Mkt. cap
64,58ย m
Avg. vol.
7,80ย k
Volume
3,66ย k
52-wk high
USDย 8,31
52-wk low
USDย 4,52
EPS
-USDย 0,08
Beta
0,47
Shares outstanding
13,92ย m
No. of employees
217
Open
USDย 4,70
High
USDย 4,70
Low
USDย 4,60
Mkt. cap
64,58ย m
Avg. vol.
7,80ย k
Volume
3,66ย k
52-wk high
USDย 8,31
52-wk low
USDย 4,52
EPS
-USDย 0,08
Beta
0,47
Shares outstanding
13,92ย m
No. of employees
217
News stories
From web sources and news partners
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Hewitt
Craig-Hallum
Buy
Maintained
USDย 12,00
+158,6%
12/16/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Okt. 2025
Jan. 2026
Apr. 2026
Jul. 2026
Revenue
15,04ย m
16,56ย m
13,84ย m
15,23ย m
Cost of goods sold
7,26ย m
8,83ย m
6,81ย m
7,53ย m
Cost of revenue
7,26ย m
8,83ย m
6,81ย m
7,53ย m
Research and development expenses
2,62ย m
2,27ย m
2,12ย m
2,34ย m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,97ย m
5,64ย m
5,43ย m
5,76ย m
Operating expense
7,59ย m
7,91ย m
7,55ย m
8,11ย m
Total operating expenses
14,85ย m
16,75ย m
14,36ย m
15,64ย m
Operating income
185,00ย k
-187,00ย k
-521,00ย k
-409,00ย k
Other non operating income
70,00ย k
39,00ย k
27,00ย k
-6,00ย k
EBT including unusual items
255,00ย k
-237,00ย k
-495,00ย k
-415,00ย k
EBT excluding unusual items
255,00ย k
-148,00ย k
-494,00ย k
-415,00ย k
Income tax expense
18,00ย k
42,00ย k
172,00ย k
11,00ย k
Effective tax rate
7,06%
-17,72%
-34,75%
-2,65%
Other operating expenses
-
-
-
-
Net income
268,00ย k
-279,00ย k
-667,00ย k
-426,00ย k
Net profit margin
1,78%
-1,68%
-4,82%
-2,80%
Earnings per share
0,06
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
542,00ย k
154,00ย k
-200,00ย k
-95,00ย k
Gain or loss from assets sale
-
90,00ย k
1,00ย k
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google-programme